BioCentury
ARTICLE | Clinical News

Hybritech Inc. regulatory update

February 24, 1997 8:00 AM UTC

Hybritech received a U.S. patent covering monoclonal antibodies that recognize the bone-specific isoenzyme of alkaline phosphatase. The enzyme is involved in bone metabolism and is a marker of skeleta...